Slides
Page 1
✓vivoryon therapeutics Transforming the Treatment of Kidney Disease Consistent eGFR Improvement Signal in Two Independent Phase 2 Studies Supports Proposed DKD Development Path Vivoryon Therapeutics N.V. August 2026
Loading workspace
✓vivoryon therapeutics Transforming the Treatment of Kidney Disease Consistent eGFR Improvement Signal in Two Independent Phase 2 Studies Supports Proposed DKD Development Path Vivoryon Therapeutics N.V. August 2026
Your watchlist and earnings event details are available after you sign in.